• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by 3M Company (Amendment)

    2/13/24 4:56:03 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care
    Get the next $MMM alert in real time by email
    SC 13G/A 1 tv0155-3mco.htm SCHEDULE 13G/A 3mco

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 10)*

    Name of issuer:  3M Co

    Title of Class of Securities:  Common Stock

    CUSIP Number:  88579Y101

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  88579Y101

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    683,607

    7.  SOLE DISPOSITIVE POWER

    46,729,293

    8.  SHARED DISPOSITIVE POWER

    2,350,916

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    49,080,209

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    8.89%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    3M Co

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    3M Center
    St. Paul, MN 55144-1000

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    88579Y101

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $MMM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MMM

    DatePrice TargetRatingAnalyst
    1/22/2025$140.00 → $170.00Equal Weight → Overweight
    Wells Fargo
    11/13/2024$184.00Neutral → Buy
    UBS
    10/22/2024Hold → Buy
    Melius
    9/6/2024$125.00Underweight
    Morgan Stanley
    7/30/2024$145.00Hold → Buy
    Argus
    7/29/2024$110.00 → $150.00Hold → Buy
    Deutsche Bank
    6/13/2024$125.00Peer Perform → Outperform
    Wolfe Research
    6/7/2024$105.00 → $120.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $MMM
    Leadership Updates

    Live Leadership Updates

    See more
    • 3M Announces New Board Appointments

      William Brown to become Chairman of the Board of DirectorsMike Roman to retire as Executive Chairman and Director and become Executive Advisor to the BoardDavid Bozeman elected to the BoardAmy Hood does not intend to stand for reelectionST. PAUL, Minn., Feb. 10, 2025 /PRNewswire/ -- 3M (NYSE:MMM) announced today changes to its Board of Directors and Board leadership structure. William M. "Bill" Brown, 3M's Chief Executive Officer and Director, has been appointed by the Board to serve as its Chairman, effective March 1, 2025 in addition to his current responsibilities.  Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman,

      2/10/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M joins consortium to accelerate semiconductor technology in the US

      ST. PAUL, Minn., Feb. 3, 2025  /PRNewswire/ -- 3M is expanding its commitment to the semiconductor industry by joining the US-JOINT Consortium, a strategic partnership of 12 leading semiconductor suppliers. The consortium drives research and development in next-generation semiconductor advanced packaging and back-end processing technologies anchored by a new cutting-edge facility in Silicon Valley. "As the demands of AI and other high performance computing technologies increase, suppliers must work together to provide comprehensive solutions to tough challenges on increasingly

      2/3/25 10:55:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M's "Green Works" docuseries spotlights how green jobs can help drive a more sustainable future

      3M's docuseries debuts at Fast Company Innovation Festival ahead of New York Climate WeekCollaboration with Work on Climate will address the critical need for more green talent and provide resources for professionals3M to emphasize importance of inspiring the workforce, closing the skills gap and developing a green economy talent pipeline during New York Climate Week eventsST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- 3M is premiering a new global docuseries today, "Green Works," to spotlight individuals working to address climate challenges and the critical need for more talent to support the green transition. The film, produced by 3M in partnership with Generous Films, features five indi

      9/18/24 3:00:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Financials

    Live finance-specific insights

    See more
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., Apr. 8, 2025 /PRNewswire/ -- 3M (NYSE: MMM) today announced the following investor event: First-quarter 2025 earnings conference call on Tuesday, Apr. 22, 2025, at 8 a.m. CT.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn how we're working to improve lives and make what's next at 3M.com/news. Investor Contact:Diane Farrow

      4/8/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Provides Medium-Term Financial Outlook at 2025 Investor Day; Presents Strategic Priorities that Will Drive Growth, Operational Excellence, and Return Cash to Shareholders

      Highlights innovation and commercial excellence initiatives that will accelerate sales growth to outperform macroOutlines operational excellence strategies to drive margin expansion, earnings growth, and strong free cash flowProvides balanced capital deployment framework focused on investing in the business and returning at least $10 billion in cash to shareholders over the outlook periodST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- 3M (NYSE:MMM) will host its 2025 Investor Day today in St. Paul, Minnesota, beginning at 8 a.m. CST. During the event, 3M will provide its medium-term financial outlook, and leadership will discuss priorities that will deliver sustainable value creation. "3M is

      2/26/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • 3M upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded 3M from Equal Weight to Overweight and set a new price target of $170.00 from $140.00 previously

      1/22/25 7:45:34 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by UBS with a new price target

      UBS upgraded 3M from Neutral to Buy and set a new price target of $184.00

      11/13/24 8:05:47 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M upgraded by Melius

      Melius upgraded 3M from Hold to Buy

      10/22/24 11:24:35 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    SEC Filings

    See more
    • SEC Form 10-Q filed by 3M Company

      10-Q - 3M CO (0000066740) (Filer)

      4/22/25 12:24:49 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - 3M CO (0000066740) (Filer)

      4/22/25 6:36:10 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by 3M Company

      DEFA14A - 3M CO (0000066740) (Filer)

      3/28/25 4:02:11 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 3M Announces Upcoming Investor Event

      ST. PAUL, Minn., April 30, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today announced the following investor event: BofA Securities Industrials, Transportation & Airlines Key Leaders Conference on Wednesday, May 14, 2025. William Brown, Chairman and Chief Executive Officer will speak at 8:45 a.m. ET.This event will be webcast live and a replay will be available on 3M's Investor Relations website at http://investors.3M.com. About 3M3M (NYSE:MMM) believes science helps create a brighter world for everyone. By unlocking the power of people, ideas and science to reimagine what's possible, our global team uniquely addresses the opportunities and challenges of our customers, communities, and planet. Learn

      4/30/25 10:10:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • 3M Reports First-Quarter 2025 Results

      GAAP sales of $6.0 billion, down 1.0% YoY; operating margin 20.9%, up 180 bps YoY; EPS of $2.04, up 61% YoYAdjusted sales of $5.8 billion with organic growth of 1.5% YoYAdjusted operating margin of 23.5%, up 220 bps YoYAdjusted EPS of $1.88, up 10% YoYOperating cash flow of $(0.1) billion with adjusted free cash flow of $0.5 billionUpdated 2025 guidance and providing tariff sensitivityST. PAUL, Minn., April 22, 2025 /PRNewswire/ -- 3M (NYSE:MMM) today reported first-quarter 2025 results. "We had strong results in the first quarter with positive organic sales growth, margins ahead of expectations and double-digit EPS growth," said William Brown, 3M Chairman and Chief Executive Officer. "In th

      4/22/25 6:30:00 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • FUTURO Brand just got an upgrade with movement in mind

      Relieve muscle and joint stiffness, soreness and swelling with our new compression sleeves that deliver comfortable wear all day long. ST. PAUL, Minn., April 16, 2025 /PRNewswire/ -- FUTURO™ Brand introduces a collection of redesigned premium compression sleeves for muscle and joint support. The new sleek look, smooth low-profile construction and ultra-soft fabric with four-way stretch delivers an unrestricted, comfortable fit, flexibility and range of motion. Prioritizing all day comfort and wear, a no-cutout construction helps reduce chafing and rubbing and an innovative comfort band with silicone beading helps prevent slipping and rolling. The reengineered compression sleeves, supported b

      4/16/25 12:13:00 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Pilz Torsten

      3 - 3M CO (0000066740) (Issuer)

      5/7/25 12:29:26 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Sr Vice President & CAO Reinseth Theresa E covered exercise/tax liability with 441 shares and exercised 1,441 shares at a strike of $142.08, increasing direct ownership by 20% to 6,008 units (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:35:54 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • Chairman & CEO Brown William M exercised 8,577 shares at a strike of $142.08 and covered exercise/tax liability with 3,912 shares (SEC Form 4)

      4 - 3M CO (0000066740) (Issuer)

      5/5/25 8:24:22 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/13/24 4:56:03 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/23 10:54:46 AM ET
      $MMM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by 3M Company (Amendment)

      SC 13G/A - 3M CO (0000066740) (Subject)

      2/9/22 3:15:56 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care

    $MMM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

      For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

      1/22/21 3:54:10 PM ET
      $MMM
      Medical/Dental Instruments
      Health Care